Single Use Bioreactor Market - Global Forecast to 2019

Single Use Bioreactor Market - Global Forecast to 2019

Regular price $5,650.00 Sale

Published on Nov 03, 2014 - 157 pages

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion's share of the global SUB market, by molecule type. However, the stem cell segment is expected to grow at the highest CAGR in the forecast period, owing to an increased focus on research in this segment.

On the basis of type of cell, the SUB market is categorized into mammalian cell, bacterial cell, yeast cell and others (insect cell and plant cell). The mammalian cell segment is expected to be the new revenue pocket in the market by type of cell. Increasing numbers of biologics are being based on mammalian cells due to their increased compatibility and bioactivity in humans.

The technology segment is subsegmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors and others (single-use reactors with vertically perforated discs and single-use hybrid reactors). Wave-induced motion SUB technology is the oldest and most widely accepted of these, which accounts for its large market share.

Research and development (R&D) of biopharmaceutical manufacturers, research institutes and contract research organizations (CROs) are the major end users of the SUB, followed by biopharmaceutical manufacturing. The large share of the R&D segment can be attributed to the wide acceptance of SUBs for small- and mid-scale biopharmaceutical manufacturing for clinical testing and R&D.

New and innovative product launches were found to be the dominant strategy adopted by key industry participants to increase their market share and cater to unmet market needs.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It also focuses on emerging and high-growth segments of the SUB market, high-growth regions, and the initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the SUB market and their product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.



Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 LIMITATION OF THE STUDY
1.3.2 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 YEARS CONSIDERED IN THE STUDY
1.6 CURRENCY
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 Key industry insights
2.2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE SINGLE-USE BIOREACTORS MARKET
4.2 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE
4.3 SINGLE-USE BIOREACTORS MARKET SNAPSHOT
4.4 SINGLE-USE BIOREACTOR MARKET, BY TECHNOLOGY
4.5 SINGLE-USE BIOREACTORS MARKET, BY END USER
4.6 LIFECYCLE ANALYSIS, BY REGION
4.7 ASIA-PACIFIC TO SHOW QUICKEST GROWTH
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
5.2.2 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE
5.2.3 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELLS
5.2.4 SINGLE-USE BIOREACTORS MARKET, BY END USER
5.3 MARKET DYNAMICS
5.3.1 IMPROVED RETURNS ON INVESTMENT FOR SMALL COMPANIES AND STARTUPS
5.3.2 REDUCED COMPLEXITY OF AUTOMATION
5.3.3 EASE IN CULTIVATION OF MARINE ORGANISMS (ALGAE)
5.3.4 POSITIVE IMPACT ON THE ENVIRONMENT
5.4 RESTRAINTS
5.4.1 REGULATORY CONCERNS RELATED TO SINGLE-USE BIOREACTORS
5.4.2 ISSUES REGARDING LEACHABLES AND EXTRACTABLES
5.4.3 DIFFICULTIES IN MEETING THE GMP STANDARDS
5.5 CHALLENGES
5.5.1 LIMITATIONS IN FLEXIBLE BIOREACTORS
5.5.2 NEED FOR IMPROVED SINGLE-USE SENSORS
5.6 OPPORTUNITIES
5.6.1 GROWING BIOLOGICS MARKET
5.7 WINNING IMPERATIVES
5.7.1 GROWING POPULARITY OF SUBS AMONG BIOPHARMACEUTICAL COMPANIES IS AN EVOLVING TREND
5.8 BURNING ISSUES
5.8.1 STABILITY OF BIOMOLECULES WHILE SHIFTING FROM SINGLE-USE SYSTEMS TO TRADITIONAL STAINLESS STEEL LEADS TO LIMITED ADOPTION OF SUBS
6 INDUSTRY INSIGHTS
6.1 INDUSTRY INSIGHTS
6.2 SUPPLY CHAIN ANALYSIS
6.2.1 KEY INFLUENCERS
6.3 PORTER'S FIVE FORCES ANALYSIS
6.3.1 THREAT FROM NEW ENTRANTS
6.3.2 THREAT FROM SUBSTITUTES
6.3.3 BARGAINING POWER OF SUPPLIERS
6.3.4 BARGAINING POWER OF BUYERS
6.3.5 INTENSITY OF COMPETITIVE RIVALRY
6.4 PESTLE ANALYSIS
6.4.1 POLITICAL FACTORS
6.4.2 ECONOMIC FACTORS
6.4.3 SOCIAL FACTORS
6.4.4 TECHNOLOGICAL FACTORS
6.4.5 ENVIRONMENTAL FACTORS
6.4.6 LEGAL FACTORS
6.5 INDUSTRY INSIGHTS
7 SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS
7.3 STIRRED TANK SINGLE-USE BIOREACTORS
7.4 SINGLE-USE BUBBLE COLUMN BIOREACTORS
7.5 OTHER TECHNOLOGIES
8 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE
8.1 INTRODUCTION
8.2 MONOCLONAL ANTIBODIES (MABS)
8.3 VACCINES
8.4 RECOMBINANT PROTEINS
8.5 STEM CELLS
8.6 GENE THERAPY
8.7 OTHERS (GROWTH FACTORS, INTERFERONS, ANTISENSE, AND RNA INTERFERENCE)
9 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL
9.1 INTRODUCTION
9.2 MAMMALIAN CELLS
9.3 BACTERIAL CELLS
9.4 YEAST CELLS
9.5 OTHERS (INSECT CELLS AND PLANT CELLS)